Director Monica Bertagnolli resigns from Natera board to lead National Cancer Institute

Natera, Inc.

Monica Bertagnolli resigned from the Board and all committees effective August 12, 2022.
Resignation due to her appointment as Director of the National Cancer Institute.
Not related to any disagreement with Natera's operations, policies, or practices.
No replacement director has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Monica Bertagnolli

Director

NTRA · Natera, Inc.

Effective: 2022-08-12
Filed: August 15, 2022, 7:59 PM ET

On August 11, 2022, Monica Bertagnolli notified the Board of Directors (the “Board”) of Natera, Inc. (“Natera” or the “Company”) of her intention to resign as a member of the Board and any committees of the Board, effective August 12, 2022, in connection with her appointment as Director of the National Cancer Institute.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Monica Bertagnolli resigned as Director at Natera, Inc..

Action: resigned
Role: Director

Exact text from the filing

On August 11, 2022, Monica Bertagnolli notified the Board of Directors (the “Board”) of Natera, Inc. (“Natera” or the “Company”) of her intention to resign as a member of the Board and any committees of the Board, effective August 12, 2022, in connection with her appointment as Director of the National Cancer Institute.

View on SEC.gov

Natera, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-091194

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.